Cercle, a California-based health tech company focusing on transforming women’s healthcare data at scale into critical insights for optimal patient service and business operations, has raised $6 million in seed funding.
The funding round was spearheaded by Outsiders Fund, with contributions from CGHealth Ventures, Rogue Women’s Fund, and FemHealth Ventures. Existing investors Sheryl Sandberg and Tom Bernthal’s SBVP fund also joined the financing round alongside angel investors.
Co-founded in 2020 by Juan Riveiro, Andreas Melder, Liya Sharif, the company developed an AI-driven healthcare insight platform, Cercle Biomedical Graph™, specifically designed to unlock women’s healthcare data at scale for use by healthcare providers to deliver personalized care and optimize business operations.
The platform transforms extensive unstructured healthcare data into vital, real-time, and high-quality insights, enabling payers, providers, and pharmaceutical firms to boost operational efficiency.
According to the company’s announcements, it will use the new funding to extend its platform’s services beyond the fertility market, boost its global footprint, and accelerate engineering and product development, including advancements in LLM offerings.
Revolutionizing Women’s Healthcare with AI Technology
Cercle Biomedical Graph™ analyzes and converts de-identified healthcare data at scale into high-quality insight in real-time. The data-driven insight can be used by women’s healthcare organizations to run more efficient businesses while also providing personalized care to patients.
With the additional funding, the company is working to connect large language models (LLMs) to high-quality healthcare data to provide accurate and secure real-time answers to many questions asked by many women’s healthcare stakeholders.
